New cell therapy for kidney disease using human kidney derived iPS cells
Project/Area Number |
23591184
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Kidney internal medicine
|
Research Institution | The University of Tokyo |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
HISHIKAWA Keiichi 東京大学, 大学院医学研究科, 特任准教授 (50255460)
|
Co-Investigator(Renkei-kenkyūsha) |
FUJITA Toshiro 東京大学, 先端研, 特任教授 (10114125)
ABRATANI Hiroyuki 東京大学, 先端研, 教授 (10202657)
|
Project Period (FY) |
2011-04-28 – 2015-03-31
|
Project Status |
Completed (Fiscal Year 2014)
|
Budget Amount *help |
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2013: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2012: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2011: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
Keywords | iPS 細胞 / 腎臓 / 再生医学 / iPS細胞 / 再生 / 再生医療 / メチル化 |
Outline of Final Research Achievements |
Human pluripotent cells are promising for treatment for kidney diseases, but the protocols for derivation of kidney cell types are still controversial. In this study, we tried to establish new cell therapy for kidney disease by using human kidney derived iPS cells. We induced kidney lineage cells from iPS cells and confirmed improvement of kidney function by using the cells.
|
Report
(5 results)
Research Products
(5 results)
-
-
[Journal Article] The role of NF-κB signaling in the maintenance of pluripotency of human induced pluripotent stem cells2013
Author(s)
Takase O, Yoshikawa M, Idei M, Hirahashi J, Fujita T, Takato T, Isagawa T, Nagae G, Suemori H, Aburatani H, Hishikawa K
-
Journal Title
PLoS One
Volume: 8(2)
Issue: 2
Pages: e56399-e56399
DOI
Related Report
Peer Reviewed
-
-
-